Clinical Trials
- Liver, HIV/AIDS, Infectious Disease
HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
- Ages18 years and older
- GenderBoth
- Liver
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)
- Ages18 years and older
- GenderBoth
- Liver
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis (PRIMIS)
- Ages18 years - 75 years
- GenderBoth
- Liver
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH (VOYAGE)
- Ages18 years - 75 years
- GenderBoth
- Liver
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) (MIRNA)
- Ages18 years - 75 years
- GenderBoth
- Liver
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis (EPICS-III)
- Ages18 years - 75 years
- GenderBoth
- Liver
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
- Ages18 years - 75 years
- GenderBoth
- Liver, Pregnancy and Obstetrics
A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)
- Ages18 years - 45 years
- GenderFemale only
- Hepatitis, Liver
Digoxin In Alcohol Associated Hepatitis
- Ages21 years - 65 years
- GenderBoth
- Children's Health, Liver
The Role of Hepatic De Novo Lipogenesis (DNL) in the Pathogenesis of Hepatic Steatosis
- Ages12 years - 30 years
- GenderBoth